Amylyx Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 4.64 M | $15.05 M | 100.00% | 6.82% |
| VANGUARD GROUP INC | 11/13/2024 | 3.09 M | $10.01 M | -26.85% | 4.54% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.55 M | $8.26 M | 100.00% | 3.74% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 2.13 M | $6.89 M | 100.00% | 3.12% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 2.02 M | $6.56 M | 10.97% | 2.97% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 2.00 M | $6.48 M | 33.17% | 2.94% |
| ALMITAS CAPITAL LLC | 11/14/2024 | 1.99 M | $6.44 M | 4.45% | 2.92% |
| ABRDN PLC | 10/25/2024 | 1.97 M | $6.39 M | 1,567.90% | 2.90% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.90 M | $6.15 M | 41.25% | 2.79% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 1.77 M | $5.73 M | 46.10% | 2.60% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.61 M | $5.23 M | -38.18% | 2.37% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.40 M | $4.55 M | 100.00% | 2.06% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.15 M | $3.73 M | 0.00% | 1.69% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 912,515 | $2.96 M | 91.09% | 1.34% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 880,745 | $2.85 M | 41.62% | 1.29% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 691,066 | $2.24 M | -47.17% | 1.01% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 670,594 | $2.17 M | 986.51% | 0.98% |
| ALPHA WAVE GLOBAL, LP | 11/13/2024 | 669,487 | $2.17 M | 100.00% | 0.98% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 649,079 | $2.10 M | -80.57% | 0.95% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 551,039 | $1.79 M | 17.53% | 0.81% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 478,440 | $1.55 M | -18.79% | 0.70% |
| MORGAN STANLEY | 11/14/2024 | 478,265 | $1.55 M | -48.27% | 0.70% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 456,816 | $1.48 M | -70.24% | 0.67% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 406,157 | $1.32 M | -8.94% | 0.60% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 367,237 | $1.19 M | -71.70% | 0.54% |
| JANE STREET GROUP, LLC | 11/15/2024 | 344,173 | $1.12 M | -29.92% | 0.51% |
| GHOST TREE CAPITAL, LLC | 11/14/2024 | 325,000 | $1.05 M | 100.00% | 0.48% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 317,800 | $1.03 M | 41.06% | 0.47% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 309,500 | $1.00 M | -73.18% | 0.45% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 302,270 | $979,355 | -42.05% | 0.44% |
| MARSHALL WACE, LLP | 11/14/2024 | 283,986 | $920,114 | 100.00% | 0.42% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 274,551 | $889,546 | 0.00% | 0.40% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 271,800 | $880,632 | -66.51% | 0.40% |
| ALDEBARAN CAPITAL, LLC | 11/13/2024 | 269,803 | $874,162 | 0.00% | 0.40% |
| UBS GROUP AG | 11/14/2024 | 229,076 | $742,206 | 660.07% | 0.34% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 221,626 | $718,068 | 59.33% | 0.33% |
| FMR LLC | 11/13/2024 | 221,001 | $716,043 | 291.99% | 0.32% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 220,906 | $715,735 | 105.87% | 0.32% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 188,465 | $610,627 | 0.00% | 0.28% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 183,894 | $595,817 | -76.70% | 0.27% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 166,429 | $539,229 | 670.50% | 0.24% |
| CITADEL ADVISORS LLC | 11/14/2024 | 160,700 | $520,668 | 15.03% | 0.24% |
| STATE STREET CORP | 11/14/2024 | 154,908 | $501,902 | 0.00% | 0.23% |
| BANK OF MONTREAL /CAN/ | 11/13/2024 | 143,512 | $442,017 | 36.35% | 0.21% |
| JPMORGAN CHASE & CO | 11/08/2024 | 140,559 | $455,411 | 144.40% | 0.21% |
| MAN GROUP PLC | 11/14/2024 | 130,862 | $423,993 | 12.69% | 0.19% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 130,000 | $421,200 | 0.00% | 0.19% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 129,290 | $418,900 | -55.31% | 0.19% |
| SHAY CAPITAL LLC | 11/14/2024 | 117,328 | $380,143 | 100.00% | 0.17% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 10/22/2024 | 114,534 | $371,090 | -3.74% | 0.17% |
Amylyx Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 145 institutional investors and hedge funds held shares of Amylyx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
TCG Crossover Management, LLC: 4.64 M
VANGUARD GROUP INC: 3.09 M
BlackRock Funding, Inc. /DE: 2.55 M
PERCEPTIVE ADVISORS LLC: 2.13 M
Alyeska Investment Group, L.P.: 2.02 M
683 Capital Management, LLC: 2 M
63.75% of Amylyx Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 45.64 M shares in the last 24 months. This purchase volume represents approximately $182.56 M in transactions.